NCT06405152

Assessment of Macrophage Activation syndromE in STill's Disease

Assessment of Macrophage Activation syndromE in STill's Disease: Retrospective Chart Analysis of Patient HistorY, Symptom Resolution and Treatment Characteristics

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 75 (actual)
• Sponsor: Swedish Orphan Biovitrum · Industry
• Sex: All
• Age: 6 Months – 80 Years
• Healthy volunteers: Not accepted

Summary

Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics

Detailed description

This is an observational, retrospective cohort study on the treatment utilization and outcomes of Macrophage Activation Syndrome (MAS) refractory to glucocorticoids (GC) in patients with Still's disease. The study will be conducted entirely through medical chart abstraction; all data will be taken from the patient's medical record, with no additional assessments.

Conditions

• Macrophage Activation Syndrome
• Still's Disease, Adult-Onset
• Stills Disease, Juvenile-Onset

Interventions

Type	Name	Description
OTHER	Chart review	Retrospective Chart Review

Timeline

• Start date: 2023-09-27
• Primary completion: 2024-09-26
• Completion: 2024-09-26
• First posted: 2024-05-08
• Last updated: 2024-10-21

Locations

11 sites across 7 countries: United States, Canada, France, Germany, Italy, Netherlands, Spain